Sudarshan Hebbar
Hoofd Techniek/Wetenschap/O&O bij CALCIMEDICA, INC.
Vermogen: 243 340 $ op 30-04-2024
Profiel
Sudarshan Hebbar is currently the Chief Medical Officer at CalciMedica, Inc. He previously worked as the Medical Director at Reata Pharmaceuticals, Inc. from 2011 to 2012, and as the Director & Vice President-Medical at Oncimmune Holdings Plc in 2013.
Sudarshan also served as the Senior Medical Director at Abbott Laboratories from 2007 to 2011.
He held the position of Vice President-Nephrology at Thrasos Therapeutics, Inc. and was a Partner at Kidney Associates of Kansas City PC from 1995 to 2007.
Sudarshan completed his undergraduate degree at The Johns Hopkins University and his graduate degree at Tulane University School of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CALCIMEDICA, INC.
0.43% | 28-03-2024 | 46 000 ( 0.43% ) | 243 340 $ | 30-04-2024 |
Actieve functies van Sudarshan Hebbar
| Bedrijven | Functie | Begin |
|---|---|---|
| CALCIMEDICA, INC. | Hoofd Techniek/Wetenschap/O&O | 01-04-2017 |
Eerdere bekende functies van Sudarshan Hebbar
| Bedrijven | Functie | Einde |
|---|---|---|
| ONCIMMUNE HOLDINGS PLC | Directeur/Bestuurslid | 01-10-2013 |
| REATA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-12-2012 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01-07-2011 |
| Kidney Associates of Kansas City PC | Corporate Officer/Principal | 01-01-2007 |
Opleiding van Sudarshan Hebbar
| The Johns Hopkins University | Undergraduate Degree |
| Tulane University School of Medicine | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| ONCIMMUNE HOLDINGS PLC | Health Technology |
| CALCIMEDICA, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
Thrasos Therapeutics, Inc.
 Thrasos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Thrasos Therapeutics, Inc. operates as a clinical-stage biotherapeutics company which focuses on bringing new solutions to kidney disease patients. It develops novel approaches to protect, treat and restore kidney function for this underserved patient group. The firms products include THR-184 to prevent AKI associated with cardiac surgery, THR-204 to treat certain forms of CKD, and the THR-800 series to treat cast nephropathy, a form of AKI associated with multiple myeloma. The company was founded by William D. Carlson and Murty Bosukonda in 2003 and is headquartered in Montreal, Canada. | Health Technology |
| Kidney Associates of Kansas City PC |
